News

High-yielding dividend stocks can make for attractive investments given the potential income they can generate for your portfolio. But there is often a trade-off when it comes to high payouts, as

Dividends never go out of style, but some dividend stocks can. That's how some investors might feel about Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY) these days. Both companies have

The stock market is on fire as 2024 kicks off. As a result, many investors might be reviewing their long-term financial goals as well as their plans for stock purchases. As always, it's best to

Stocks across a range of sectors have been feeling the market volatility over the last few years. Even as stocks have rebounded considerably in recent months -- the S&P 500 is trading up by around

A lot can change on the stock market in just a few years, and Pfizer (NYSE: PFE) is a great example. At the end of 2021, its shares were trading at around $60, and things were looking great for the

With the stock market recently hitting new all-time highs again, times are exciting for people who are fully invested, but these conditions can be more frustrating for those who have cash available

UnitedHealth Group (NYSE: UNH) is one of the largest healthcare companies in the world. Its market cap sits at around $470 billion. And this is a stock that has risen tremendously in value. In the

Some of the best dividend stocks don't have the best yields -- yet. And that's because their businesses are still experiencing some strong growth and they have to set some cash aside to help fund

Pfizer (NYSE: PFE) celebrates its 175th anniversary this year, so the pharma giant has a long history. But the drugmaker actually jumped into the global spotlight not long ago when it launched its

Image source: The Motley Fool.

Pfizer (NYSE: PFE)Q4 2023 Earnings CallJan 30, 2024, 10:00 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Pfizer (NYSE: PFE) jumped as much as 3.2% higher on Tuesday morning before giving up all of the gains and then some. The pharma stock was down by 0.6% as of 12:05 p.m. ET.

These gyrations

Famed investor Warren Buffett once said he aimed to be greedy when others were fearful. Here's one way to apply this bit of advice when investing in stocks: Equities that look beaten-down can be

Microsoft, Apple, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla -- a group that Bank of America analyst Michael Hartnett dubbed the "Magnificent Seven," -- have taken the market by storm for

Pfizer (NYSE: PFE) has reached a major transition point. The big pharma company took center stage earlier in the COVID-19 pandemic when it became the first to launch a coronavirus vaccine. That

UnitedHealth Group (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ) are two of the largest healthcare companies in the world. One is focused on health insurance, while the other makes medical devices

Building a balanced portfolio requires careful planning and execution. You need to think about your long-term objectives for growth and income, as well as tax implications, when you need to adjust

I can sum up Pfizer's (NYSE: PFE) stock performance over the last couple of years in one word (and only three letters): ugh. Shares of the big drugmaker have plunged more than 50% since the high set

Pfizer (NYSE: PFE) ended 2022 with a bang, delivering its highest level of revenue ever -- $100 billion -- thanks to its coronavirus vaccine and treatment. But the drop in demand for those products

The new year is here, and for many, it's a fresh opportunity to set financial goals and find fresh stocks to consider adding to a portfolio. The types of stocks you gravitate toward will broadly be

The healthcare sector is home to many excellent, innovative corporations that have made many investors richer. However, no healthcare company has reached a market capitalization of $1 trillion

COVID-19 has been especially rough for Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) investors over the last couple of years. Shares of both drugmakers have plunged as the demand for their

One of the most important companies during the peak of the COVID-19 pandemic was pharmaceutical giant Pfizer (NYSE: PFE). The company's breakthrough vaccine helped pave the way for a post-pandemic

For all of its many successes, the healthcare industry isn't exactly a hotbed of dividend-paying stocks. However, this doesn't mean the sector is entirely without companies that remunerate their

If you're in the process of rebalancing your portfolio, you might be considering buying Pfizer (NYSE: PFE) stock. After all, the drugmaker pays a sizzling 5.92% dividend yield, its shares trade at

Last year, pharmaceutical giant Pfizer (NYSE: PFE) encountered several issues, none more significant than the massive drop in revenue and earnings it experienced due to a shrinking coronavirus